跳至主要内容
临床试验/NCT02703948
NCT02703948已完成不适用

Injection Technique Assessment of Restylane Silk With Lidocaine for Lip Augmentation

Galderma R&D4 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2016年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Galderma R&D
入组人数
60
试验地点
4
主要终点
Number of Participants With Adverse Events With the Use of Restylane Silk With Lidocaine

研究概览

简要总结

This is a multi-center, open-label, single-arm study to assess the safety of an injection technique with Restylane Silk in lip augmentation and correction of perioral rhytids .

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Subjects willing to comply with the requirements of the study and providing written informed consent including release of copyright of photography images.
  • •Males or females, 22 years of age or older
  • •Subjects seeking augmentation therapy for the lips.

排除标准

  • •History of allergy or hypersensitivity to injectable HA gel or to gram positive bacterial proteins.
  • •History of allergy or hypersensitivity to lidocaine, other amide type anesthetics, or topical anesthetics or nerve blocking agents
  • •Previous surgery to the upper or lower lip, lip piercing or tattoo, or history of facial trauma.

研究组 & 干预措施

Restylane Silk with Lidocaine

Other

干预措施: Restylane Silk with Lidocaine (Device)

结局指标

主要结局

Number of Participants With Adverse Events With the Use of Restylane Silk With Lidocaine

时间窗: 12 weeks

次要结局

未报告次要终点

研究者

发起方
Galderma R&D
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验